Clinical Trial Service Unit, Richard Doll Building, Oxford, UK.
Radiother Oncol. 2011 Aug;100(2):176-83. doi: 10.1016/j.radonc.2011.01.020. Epub 2011 Mar 4.
To estimate target and cardiac doses from breast cancer radiotherapy in Denmark and in the Stockholm and Umeå areas of Sweden during 1977-2001.
Representative samples of irradiated women were identified from the databases of the Danish Breast Cancer Cooperative Group and the Swedish Nationwide Cancer Registry. Virtual simulation, computed tomography planning and manual planning were used to reconstruct radiotherapy regimens on a typical woman. Estimates of target dose and various measures of cardiac dose were derived from individual radiotherapy charts.
Doses were estimated in 681 Danish and 130 Swedish women. Mean heart dose for individual women varied from 1.6 to 14.9 Gray in Denmark and from 1.2 to 22.1 Gray in Sweden. In Denmark, mean target doses averaged across women increased from 40.6 to 53.8 Gray during 1977-2001 but, despite this, mean heart dose averaged across women remained around 6 Gy for left-sided and 2-3 Gray for right-sided radiotherapy. In Sweden mean target dose averaged across women increased from 38.7 to 46.6 Gray during 1977-2001, while mean heart dose averaged across women decreased from 12.0 to 7.3 Gray for left-sided and from 3.6 to 3.2 Gray for right-sided radiotherapy. Temporal trends for mean biologically effective dose [BED] to the heart, mean dose to the left anterior descending coronary artery, the right coronary artery and the circumflex coronary artery were broadly similar.
Cardiac doses in Denmark were low relative to those in Sweden. In both countries, target dose increased during 1977-2001. Despite this, cardiac doses remained constant in Denmark and decreased in Sweden.
本研究旨在估算 1977 年至 2001 年期间丹麦以及瑞典斯德哥尔摩和于默奥地区乳腺癌放疗的靶区和心脏剂量。
从丹麦乳腺癌合作组数据库和瑞典全国癌症登记处中选择接受放疗的女性患者作为代表性样本。采用虚拟模拟、计算机断层扫描(CT)计划和手动计划对典型女性患者的放疗方案进行重建。从每位患者的个体化放疗计划中获取靶区剂量和各种心脏剂量的测量值。
丹麦有 681 名女性和瑞典有 130 名女性的剂量数据被估算出来。在丹麦,每位女性的心脏剂量均值从 1.6 到 14.9 戈瑞不等,而在瑞典则从 1.2 到 22.1 戈瑞不等。在丹麦,1977 年至 2001 年间,女性靶区剂量均值从 40.6 增至 53.8 戈瑞,但尽管如此,左乳腺癌侧放疗的女性心脏剂量均值仍保持在 6 戈瑞左右,右乳腺癌侧放疗的女性心脏剂量均值仍保持在 2-3 戈瑞左右。在瑞典,女性靶区剂量均值从 1977 年至 2001 年的 38.7 增至 46.6 戈瑞,而女性心脏剂量均值从左乳腺癌侧放疗的 12.0 降至 7.3 戈瑞,从右乳腺癌侧放疗的 3.6 降至 3.2 戈瑞。心脏的生物有效剂量[BED]均值、左前降支冠状动脉、右冠状动脉和回旋支冠状动脉的平均剂量均呈现出相似的趋势。
丹麦的心脏剂量相对较低,而瑞典的心脏剂量较高。在这两个国家,靶区剂量在 1977 年至 2001 年间均有所增加。尽管如此,丹麦的心脏剂量保持不变,而瑞典的心脏剂量却有所降低。